Home › Multiple Sclerosis › New York › New York City
Multiple Sclerosis clinical trials in New York City, NY
17 studies for Multiple Sclerosis are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of the MIND Diet for Persons With Multiple Sclerosis
Recruiting
- Mount Sinai Hospital, New York
Vancomycin Study in Multiple Sclerosis (MS)
RecruitingPhase 1
- Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
RecruitingObservational study
- TG Therapeutics Investigational Trial Site, New York
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
RecruitingPhase 1/2
- Mt. Sinai, New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- NYU Langone Health, New York
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
RecruitingPhase 1
- TG Therapeutics Investigational Trial Site, New York
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
RecruitingPhase 1
- Research Site, New York
- Research Site, New York
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
RecruitingPhase 1
- Columbia University Irving Medical Center, New York
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
RecruitingPhase 2
- Mount Sinai School of Medicine, New York
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
RecruitingPhase 2
- NYU Langone Health, New York
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
RecruitingObservational studyHealthy volunteers welcome
- Mount Sinai Hospital, New York
Genes and Environment in Multiple Sclerosis
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Irving Center, New York
A Palliative Care Model Impact on Knowledge and Attitudes
Recruiting
- Judith Jaffe Multiple Sclerosis Center, New York
- Hunter College, New York
NYSCF Scientific Discovery Biobank
RecruitingObservational study
- New York Stem Cell Foundation Research Institute, New York
Eccentric Exercise and Fatigue in Multiple Sclerosis
RecruitingObservational study
- Hunter College, Physical Therapy Department, City University of New York, New York
Effect of Cooling on Balance Performance in Multiple Sclerosis
RecruitingObservational study
- Hunter College, Physical Therapy Department, City University of New York, New York
About Multiple Sclerosis
Multiple sclerosis (MS) slows down or blocks messages between the brain and body. MS can be mild or severe. Learn about MS symptoms and treatment.
More about Multiple Sclerosis on MedlinePlus
Multiple Sclerosis trials in other cities
- Chicago, IL15 studies
- Boston, MA14 studies
- Washington, DC13 studies
- Cleveland, OH9 studies
- St. Louis, MO8 studies
- Kansas City, KS8 studies
- Birmingham, AL8 studies
- San Francisco, CA8 studies
- Columbus, OH7 studies
- Aurora, CO7 studies
- Baltimore, MD7 studies
- Farmington Hills, MI6 studies
Other studies in New York City
- Breast Cancer134 studies
- Non-Small Cell Lung Cancer120 studies
- Cancer (all types)110 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer77 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Pancreatic Cancer60 studies
- Multiple Myeloma60 studies
- Endometrial Cancer52 studies
- Heart Failure51 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.